Substance use & recovery

The Questions Worth Asking Before You Commit

Save

Choosing a program is one of the highest-stakes decisions a family makes under the worst possible conditions, usually in a hurry and often over the phone. The right questions cut through the brochure language fast, because a good program answers them directly and a predatory one changes the subject. These are the ones that reveal what a facility is really selling, and the answers you can check afterward.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How do you decide my level of care?

This is the first question, and the answer tells you almost everything. A credible program decides your level of care through an individualized clinical assessment, not a phone script. The American Society of Addiction Medicine defines a continuum from outpatient through medically managed inpatient, and holds that placement should match an individual's assessed severity rather than a fixed package 1. If a program can tell you how many days you need before anyone has assessed you, it is describing its calendar, not your care.

The assessment should weigh withdrawal risk, physical health, mental health, prior attempts, and living situation. Ask what it covers and who performs it. Ask, too, what happens if the assessment finds you need less than you called for. The honest answer is sometimes outpatient rather than residential; vetting a rehab starts with a program willing to say so, because it means the recommendation follows the clinical picture and not the room rate.

It is reasonable to ask the program to walk you through how the assessment turns into a recommendation. Who conducts it, how long it takes, what it screens for, and how its findings map to a level of care are all fair questions, and a credible program answers them without defensiveness. The point is not to become an expert overnight; it is to confirm that a clinical process, and not a sales target, stands between you and the plan being proposed.

Which medications do you offer, and for what?

Whether a program offers medication, and which, is one of the sharpest quality signals. For alcohol use disorder, three medications are FDA-approved; they are not addictive, they can be used with or without counseling, and they remain substantially underused 2. A program that dismisses medication for alcohol or opioid use as "a crutch" or "replacing one drug with another" is out of step with the evidence, and that phrase is worth noticing when you hear it.

For opioid use disorder, the standard of care includes medication, and programs that dispense methadone operate under federal rules as certified opioid treatment programs, accredited by a SAMHSA-approved body 3. Ask directly: do you offer medication for this substance, which ones, and who prescribes them? Asking whether a rehab is evidence based is not confrontational. It is the single question most likely to separate real medicine from a philosophy being sold as medicine.

What therapies do you use, and are they evidence-based?

Beyond medication, ask which behavioral therapies the program uses and what evidence supports them. Quality treatment spans levels of intensity, from outpatient through inpatient, and combines behavioral therapy, medication, and mutual-help support as evidence-based options chosen by assessment 5. One worth asking about specifically is contingency management, which is among the most effective treatments for stimulant use disorder, the category for which no medication is FDA-approved 4.

The reason the question matters is that "evidence-based treatment" has become a marketing phrase as often as a practice. Ask what a typical week looks like, how much of it is individual versus group, and how the program would describe the evidence behind its approach. A program comfortable naming its methods and their limits is showing you something real. Understanding what evidence-based treatment actually means turns a slogan back into a claim you can check.

What is the total cost, and what happens when insurance runs out?

Money is where pressure hides, so ask for the total cost in writing and ask it early. A trustworthy program will give you an itemized picture: the daily or program rate, what insurance is expected to cover, what your share is likely to be, and, crucially, what happens if a benefit is exhausted partway through treatment. Vagueness on cost is itself an answer.

Ask specifically what happens if you need to step down to a lower level of care mid-treatment, whether that lowers the cost, and whether the program has any financial incentive to keep you at its most expensive level. Whether a program is independent vs chain can shape these answers, because ownership structure affects how billing decisions get made. The questions they dodge, the ones met with "let's talk about that after you arrive," tend to be the ones about money and about leaving.

It is also fair to ask what the price actually buys. Two programs quoting a similar number can deliver very different amounts of licensed clinical care, and the difference is rarely in the brochure. Ask how many hours of individual therapy and physician time the fee includes each week, not just how many days the stay lasts. A high price attached to mostly unstructured time is not a bargain, and a lower price with substantial clinical contact may be the better care.

How long will I stay, and who decides?

Be wary of a fixed number offered before any assessment. The abstinence-based residential rehab tradition in the United States traces to the Minnesota Model developed at Hazelden and related programs beginning in the late 1940s and 1950s 6; the classic 28-day length is a historical inheritance from that era, not evidence that 28 days is the right dose of treatment for a given person. Length of stay should follow the assessment and your progress, not a number set decades ago for billing and scheduling convenience.

Ask how the program decides when you are ready to step down or to discharge, whether that decision is clinical or tied to a set program length, and what the plan is for continuing care afterward. Recovery is not an event that ends at the door; ask what happens on day 29. A program that treats discharge as a clinical decision, revisited as you change, is describing care. One that treats it as a countdown is describing a product. It is worth asking, too, whether the typical length of stay is set by clinical judgment or by what insurance will authorize, because those are not always the same thing, and an honest program will tell you which one is driving the number.

Who will actually be treating me, and what are their credentials?

Ask who provides the care, not just what the care is called. In a good program, treatment is delivered by licensed clinicians: physicians or nurses where medication is involved, licensed therapists, and credentialed counselors, and the program can describe their qualifications without hesitation. Ask what the ratio of clinical staff to patients is, who oversees medical care, and whether a physician is involved in decisions about medication.

The question matters because "therapy" and "counseling" are used loosely in marketing. A daily schedule can look full while containing very little licensed clinical time; group activities led by unlicensed staff are not the same as evidence-based therapy delivered by a trained clinician. Peer support and the involvement of people with lived experience are genuinely valuable, but they supplement professional treatment rather than replacing it.

Ask, too, how the program handles co-occurring mental-health conditions, because depression, anxiety, trauma, and substance use very often travel together. A program that treats the substance use in isolation, with no way to address what sits underneath it, is offering half of what many people need. A program that can name its clinicians and their credentials, and explain who handles medical and mental-health care, is describing a treatment team; one that cannot is describing a building.

What happens if I relapse or need to change course?

Ask what the program does when treatment does not go in a straight line, because it rarely does. Addiction is a relapsing condition, and a relapse is a clinical event to respond to, not a moral failure to punish or a reason to discharge someone into nothing. A thoughtful program can describe how it adjusts the plan: stepping up to a higher level of care, adding or changing medication, revisiting the assessment rather than repeating the same month unchanged.

This is where the assessment-based model shows its value again. Because placement follows assessed need rather than a fixed package, a legitimate program can move you along the continuum of care as your situation changes, up when you are struggling and down when you stabilize 1. Ask specifically what happens on the day you complete the program: what the continuing-care plan is, how medication is maintained, and how the program connects you to ongoing support.

The answers reveal whether the program thinks of treatment as a single episode or as the start of something longer. A relapse is a common part of recovery, and a good program plans for it rather than treating it as the end of the road. A facility with no answer beyond "finish the 30 days" is offering a finish line where there should be a bridge to what comes next.

How do I check what you told me?

The last question is the one you ask yourself: can I verify this? Every important claim a program makes, its license, its accreditation, and whether its level-of-care recommendation actually follows an assessment, should be checkable against a source that does not profit from your decision 1. Write down what you were told, then confirm it independently before you commit money or travel anywhere.

The same questions apply at every level of care, not only residential. Vetting an outpatient program means asking the same things about assessment, medication, evidence-based therapy, and cost, because intensive outpatient and standard outpatient care are legitimate levels on the continuum, chosen by assessment rather than by default 5. Asking to verify does not offend a good program; it is exactly what a good program expects a careful person to do.

A useful habit is to take notes during the call and to ask for the important answers in writing: a short email confirming the level of care, the total cost, and what is included. A legitimate program will send it. Evasion in writing is harder to explain away than evasion on a warm phone call, which is part of why a program that is selling rather than treating tends to prefer keeping everything verbal and everything urgent.

Common questions

How do you decide my level of care? A credible program answers that an individualized clinical assessment decides it, weighing withdrawal risk, health, mental health, and history. A program that names a fixed number of days before anyone has assessed you is describing its schedule, not your needs. That one answer predicts most of what follows.

Yes. Whether a program offers medication, and how it talks about it, is a quality signal regardless of your eventual choice. FDA-approved medications exist for alcohol and opioid use disorders and are underused. A program that reflexively calls medication "a crutch" is out of step with the evidence, and that alone tells you something about its approach.

Ask for the total cost in writing, what insurance is expected to cover, and what happens if a benefit runs out mid-treatment. These are ordinary questions, and a legitimate program expects them. Difficulty answering, or a push to sort out money after you arrive, is the signal, not your asking. Cost clarity protects you from pressure.

No. The right length follows your assessment and your progress, not a fixed number. The familiar 28-day program is a historical artifact rather than a clinically optimal dose. Ask how the program decides when you are ready to step down, and what continuing care looks like afterward. A countdown to a set discharge date is a scheduling decision, not a clinical one.

Treat evasion as an answer. A trustworthy program explains how it assesses you, what it offers, what it costs, and how it handles a relapse, and it does not punish the questions with pressure to commit today. If the friendly voice keeps changing the subject or urging you to decide now, that is a reason to slow down and look elsewhere.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When it is a medical emergency, not a decision to weigh

  • Signs of opioid overdose in someone who has used: slow or stopped breathing, blue or gray lips or fingertips, and being impossible to wake
  • Alcohol or benzodiazepine withdrawal with shaking, a racing heart, confusion, hallucinations, or a seizure, which can be life-threatening
  • Any thoughts of suicide or of not wanting to be alive

If someone may be overdosing or is having a withdrawal seizure, call 911 immediately, and use naloxone if it is on hand. For thoughts of suicide, call or text 988 (the Suicide and Crisis Lifeline), or text HOME to 741741.

This article lists questions that help you evaluate a treatment program. It is not medical advice and cannot tell you which program or level of care is right for any individual. An in-person clinical assessment does that.

References

  1. 1.American Society of Addiction Medicine (2024). The ASAM Criteria. American Society of Addiction Medicine (ASAM). linkThat ASAM defines a continuum of levels of care and that placement should follow an individual's assessed severity rather than a fixed program, which is what a program's level-of-care answer should reflect.
  2. 2.National Institute on Alcohol Abuse and Alcoholism (2024). Recommend Evidence-Based Treatment: Know the Options. National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. linkThat three FDA-approved medications treat alcohol use disorder, that they are non-addictive and can be used with or without counseling, and that they are substantially underused.
  3. 3.Office of the Federal Register (eCFR) (2024). 42 CFR Part 8 — Medications for the Treatment of Opioid Use Disorder. Electronic Code of Federal Regulations (eCFR). linkThat programs providing methadone for opioid use disorder operate as federally certified opioid treatment programs accredited by a SAMHSA-approved body.
  4. 4.National Academies of Sciences, Engineering, and Medicine (2023). Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention. National Academies (NCBI Bookshelf). linkThat contingency management is a strongly evidence-based behavioral treatment and among the most effective interventions for stimulant use disorder, for which no medication is FDA-approved.
  5. 5.National Institute on Alcohol Abuse and Alcoholism (2024). Types of Alcohol Treatment — Alcohol Treatment Navigator. National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. linkThat quality treatment spans levels of intensity chosen by assessment and that behavioral therapy, medication, and mutual-help support are all evidence-based options.
  6. 6.Hazelden Betty Ford Foundation (2020). The Minnesota Model. Hazelden Betty Ford Foundation. linkThat the abstinence-based Minnesota Model of residential addiction treatment was developed at Hazelden and related programs beginning in the late 1940s and 1950s.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy